Aceprometazine
Jump to navigation
Jump to search
This article needs additional citations for verification. (February 2020) |
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal and fecal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.033.315 |
Chemical and physical data | |
Formula | C19H22N2OS |
Molar mass | 326.46 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Aceprometazine (INN) is a phenothiazine derivative prescription drug with neuroleptic and anti-histamine properties It is not widely prescribed, and may be associated with drug-induced Parkinsonism.[1] It may be used in combination with meprobamate for the treatment of sleep disorders. This combination is available in France under the trade name Mepronizine.
It is structurally related to the phenothiazine derivative veterinary drug acepromazine.
Synthesis
Note: The reason for the rearrangement in the sidechain between the precursor and the product is on account of a methadone-type aziridine.
2-Acetylphenothiazine [6631-94-3] (1) 2-Chloropropyldimethylamine [108-14-5] (2)
References
- ^ Blanchet PJ, Kivenko V (2016-09-23). "Drug-induced parkinsonism: diagnosis and management". Journal of Parkinsonism and Restless Legs Syndrome: 83–91. doi:10.2147/JPRLS.S99197. hdl:1866/19491.
- ^ Martin L Kantor & Tubis Samuel, U.S. patent 3,100,772 (1963 to Wyeth LLC).
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from February 2020
- All articles needing additional references
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- ECHA InfoCard ID from Wikidata
- Articles without KEGG source
- D2 antagonists
- Phenothiazines
- H1 receptor antagonists
- Aromatic ketones
- All stub articles
- Nervous system drug stubs